News

Topical pranoprofen 0.1% reduces the ocular signs and symptoms of dry eyes and decreases inflammatory markers of conjunctival epithelial cells.

The National Institute for Health and Clinical Excellence (NICE) recommends the use of ranibizumab for patients with diabetic macular oedema (DME).

Juan F. Tabernero, PhD, was announced as the winner of the 2012 Carl Zeiss European Young Investigator Award during the EVER Congress in Nice, France.